Piramal Pharma Ltd. logo

Piramal Pharma Ltd. share price

NSE: PPLPHARMA · Healthcare

₹244.93 +0.16%

Closing price data, updated 17 Nov 2026. 52-week range: -3.5% from high, +85.1% above low.

Price₹244.93
Market cap₹32,480 Cr
P/E–
P/B3.99
ROE-4.0%
ROCE1.2%
Debt / equity0.70
Dividend yield0.00%
EPS₹-1.57
Book value₹61.40
Operating margin1.8%
Dipscan score24 / 100
Open full analysis, charts & financials →

Share: WhatsAppX / TwitterTelegram

Piramal Pharma Ltd. shareholding pattern

As of Sep 2026: Promoters 34.80%, FIIs 13.65%, DIIs 14.44%, Government 0.00%, Public 13.27%, Others 23.84%.

HolderSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025
Promoters34.80%34.80%34.86%34.86%34.86%34.86%
FIIs13.65%12.52%30.18%29.66%30.27%30.86%
DIIs14.44%14.57%15.61%15.69%14.89%14.26%
Government0.00%0.00%0.00%0.00%0.00%0.00%
Public13.27%14.54%13.74%14.11%19.47%19.45%
Others23.84%23.57%5.61%5.69%––
No. of Shareholders413,197461,096450,661453,830462,511458,430

As filed by the company with the exchanges.

Returns

1 day1 week1 month3 months6 months1 year
+0.16%+2.34%+26.29%+15.17%+40.31%+26.11%

Growth

Sales growth, 3 years+7.6%
Sales growth, 5 years–
Profit growth, 3 years–
Profit growth, 5 years–
Latest quarter sales vs last year–
Latest quarter profit vs last year–

Strengths and weaknesses

Weaknesses

Peers in Healthcare

CompanyPriceMarket capP/EROE1 year
Sun Pharmaceutical Industries ₹1,867.50₹4,48,076 Cr40.914.7%+8.8%
Divi's Laboratories Ltd.₹11,080.00₹2,94,139 Cr87.516.2%+69.4%
Torrent Pharmaceuticals Ltd.₹4,691.20₹1,78,438 Cr84.027.1%+22.6%
Apollo Hospitals Enterprise Lt₹8,771.00₹1,26,114 Cr56.221.9%+16.9%
Laurus Labs Ltd.₹2,220.00₹1,19,949 Cr89.518.2%+125.2%
Zydus Lifesciences Ltd.₹1,192.00₹1,18,902 Cr28.419.7%+27.0%
Dr. Reddy's Laboratories Ltd.₹1,377.90₹1,14,778 Cr41.012.1%+13.7%
Cipla Ltd.₹1,394.50₹1,12,658 Cr38.911.8%-8.0%

Frequently asked questions

What is the share price of Piramal Pharma Ltd.?

Piramal Pharma Ltd. (PPLPHARMA) last closed at ₹244.93 (+0.16% on the day).

What is the market cap of Piramal Pharma Ltd.?

About ₹32,480 Cr.

What is the P/E ratio of Piramal Pharma Ltd.?

The price-to-earnings ratio is –, and return on equity is -4.0%.

Figures are calculated from company results and exchange prices and are for information only.